Cargando…
Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway
Malaria is a major parasitic disease of humans and is a health public problem that affects more than 100 countries. In 2017, it caused nearly half a million deaths out of 219 million infections. Malaria is caused by the protozoan parasites of the genus Plasmodium and is transmitted by female mosquit...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789167/ https://www.ncbi.nlm.nih.gov/pubmed/31604978 http://dx.doi.org/10.1038/s41598-019-51193-x |
_version_ | 1783458593746452480 |
---|---|
author | Kluck, George Eduardo Gabriel Wendt, Camila Hübner Costabile Eustaquio do Imperio, Guinever Araujo, Maria Fernanda Carvalho Atella, Tainá Correa da Rocha, Isabella Miranda, Kildare Rocha Atella, Georgia Correa |
author_facet | Kluck, George Eduardo Gabriel Wendt, Camila Hübner Costabile Eustaquio do Imperio, Guinever Araujo, Maria Fernanda Carvalho Atella, Tainá Correa da Rocha, Isabella Miranda, Kildare Rocha Atella, Georgia Correa |
author_sort | Kluck, George Eduardo Gabriel |
collection | PubMed |
description | Malaria is a major parasitic disease of humans and is a health public problem that affects more than 100 countries. In 2017, it caused nearly half a million deaths out of 219 million infections. Malaria is caused by the protozoan parasites of the genus Plasmodium and is transmitted by female mosquitoes of the genus Anopheles. Once in the bloodstream, Plasmodium merozoites invade erythrocytes and proliferate until the cells lyses and release new parasites that invade other erythrocytes. Remarkably, they can manipulate the vertebrate host’s lipid metabolism pathways, since they cannot synthesize lipid classes that are essential for their development and replication. In this study, we show that mice infected with Plasmodium chabaudi present a completely different plasma profile from control mice, with marked hyperproteinemia, hypertriglyceridemia, hypoglycemia, and hypocholesterolemia. In addition, white adipose and hepatic tissue and analyses from infected animals revealed the accumulation of triacylglycerol in both tissues and free fatty acids and free cholesterol in the liver. Hepatic mRNA and protein expression of key enzymes and transcription factors involved in lipid metabolism were also altered by P. chabaudi infection, leading to a lipogenic state. The enzyme 5′ AMP-activated protein kinase (AMPK), a master regulator of cell energetic metabolism, was also modulated by the parasite, which reduced AMPK phosphorylation levels upon infection. Pretreatment with metformin for 21 days followed by infection with P. chabaudi was effective in preventing infection of mice and also lowered the hepatic accumulation of lipids while activating AMPK. Together, these results provide new and important information on the specific molecular mechanisms induced by the malaria parasite to regulate hepatic lipid metabolism in order to facilitate its development, proliferation, and lifespan in its vertebrate host. |
format | Online Article Text |
id | pubmed-6789167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-67891672019-10-21 Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway Kluck, George Eduardo Gabriel Wendt, Camila Hübner Costabile Eustaquio do Imperio, Guinever Araujo, Maria Fernanda Carvalho Atella, Tainá Correa da Rocha, Isabella Miranda, Kildare Rocha Atella, Georgia Correa Sci Rep Article Malaria is a major parasitic disease of humans and is a health public problem that affects more than 100 countries. In 2017, it caused nearly half a million deaths out of 219 million infections. Malaria is caused by the protozoan parasites of the genus Plasmodium and is transmitted by female mosquitoes of the genus Anopheles. Once in the bloodstream, Plasmodium merozoites invade erythrocytes and proliferate until the cells lyses and release new parasites that invade other erythrocytes. Remarkably, they can manipulate the vertebrate host’s lipid metabolism pathways, since they cannot synthesize lipid classes that are essential for their development and replication. In this study, we show that mice infected with Plasmodium chabaudi present a completely different plasma profile from control mice, with marked hyperproteinemia, hypertriglyceridemia, hypoglycemia, and hypocholesterolemia. In addition, white adipose and hepatic tissue and analyses from infected animals revealed the accumulation of triacylglycerol in both tissues and free fatty acids and free cholesterol in the liver. Hepatic mRNA and protein expression of key enzymes and transcription factors involved in lipid metabolism were also altered by P. chabaudi infection, leading to a lipogenic state. The enzyme 5′ AMP-activated protein kinase (AMPK), a master regulator of cell energetic metabolism, was also modulated by the parasite, which reduced AMPK phosphorylation levels upon infection. Pretreatment with metformin for 21 days followed by infection with P. chabaudi was effective in preventing infection of mice and also lowered the hepatic accumulation of lipids while activating AMPK. Together, these results provide new and important information on the specific molecular mechanisms induced by the malaria parasite to regulate hepatic lipid metabolism in order to facilitate its development, proliferation, and lifespan in its vertebrate host. Nature Publishing Group UK 2019-10-11 /pmc/articles/PMC6789167/ /pubmed/31604978 http://dx.doi.org/10.1038/s41598-019-51193-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Kluck, George Eduardo Gabriel Wendt, Camila Hübner Costabile Eustaquio do Imperio, Guinever Araujo, Maria Fernanda Carvalho Atella, Tainá Correa da Rocha, Isabella Miranda, Kildare Rocha Atella, Georgia Correa Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway |
title | Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway |
title_full | Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway |
title_fullStr | Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway |
title_full_unstemmed | Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway |
title_short | Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway |
title_sort | plasmodium infection induces dyslipidemia and a hepatic lipogenic state in the host through the inhibition of the ampk-acc pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789167/ https://www.ncbi.nlm.nih.gov/pubmed/31604978 http://dx.doi.org/10.1038/s41598-019-51193-x |
work_keys_str_mv | AT kluckgeorgeeduardogabriel plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway AT wendtcamilahubnercostabile plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway AT eustaquiodoimperioguinever plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway AT araujomariafernandacarvalho plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway AT atellatainacorrea plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway AT darochaisabella plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway AT mirandakildarerocha plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway AT atellageorgiacorrea plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway |